https://www.wsj.com/articles/indias-vaccine-colossus-is-a-model-for-the-world-to-follow-11609930891
Indian Vaccine Colossus is a model the world should follow
danielredmayne10 hours ago
India has approved the use of two Covid-19 vaccines, highlighting its enormous vaccine production capacity. Most of the rich world may have something worth learning.
The Serum Institute of India is the world’s largest vaccine maker, founded more than 50 years ago by now billions of Cyrus Punewara. If exports are approved by the end of the year, it is possible that not only almost all vaccines given in India, but many vaccines will be available elsewhere in the world.
The Fitch Solutions survey provides an overview of the three groups of Asian economies this year. Most people in priority groups, such as health care workers and the elderly, can be vaccinated by June, vaccinated by September, and more time consuming. .. India is the lowest-income country in the first economic group, including Hong Kong, China, Singapore and Malaysia. Wealer South Korea and Thailand will take longer.
The Serum Institute’s work requires a reliable, high-volume domestic supply of vials in which vaccines are sealed and transported, assured by companies such as Schott Kaisha and Pilamar Glass. The presence of the world’s largest vaccine manufacturer helps to lay the foundation for a domestic network of suppliers.
The world’s supply chain and international trade have actually held up very well in extreme circumstances over the past year. There is no need to rebuild huge volumes of manufacturing capacity, and attempts at a half-hearted closed economy will reduce the prosperity of all involved (importers and exporters).
But when it comes to manufacturing important items that may face a massive surge in demand, and when national priorities come to the fore, countries can take a break from Indian books. Doing so is impractical for all small and medium-sized countries, but production can be organized at the level of regional blocks such as the Association of Southeast Asian Nations. The pandemic has hit Latin America more than many other parts of the world, but due to limited vaccine production, most countries have been waiting in front of them for a long time.
Such a company does not have to be a state-owned enterprise. As mentioned earlier, the Serum Institute works closely with the government, but was founded as a private sector and is still a private sector. Establishing similar capabilities can be achieved through cooperation on healthcare regulation and appropriate financial incentives to create large regional markets. This principle applies explicitly to personal protective equipment as well as vaccines.
Many much wealthier countries are plagued by a shortage of these important components, as they are usually imported, and the demand is so high that supply is currently uncertain. Given the very slow pace of European vaccine deployment, the Indian program has the potential to become a model for the world.
Write to Mike Bird at Mike.Bird@wsj.com
Copyright © 2020 DowJones & Company, Inc. all rights reserved. 87990cbe856818d5eddac44c7b1cdeb8
Indian Vaccine Colossus is a model the world should follow
Indian Vaccine Colossus is a model the world should follow
danielredmayne10 hours ago
India has approved the use of two Covid-19 vaccines, highlighting its enormous vaccine production capacity. Most of the rich world may have something worth learning.
The Serum Institute of India is the world’s largest vaccine maker, founded more than 50 years ago by now billions of Cyrus Punewara. If exports are approved by the end of the year, it is possible that not only almost all vaccines given in India, but many vaccines will be available elsewhere in the world.
The Fitch Solutions survey provides an overview of the three groups of Asian economies this year. Most people in priority groups, such as health care workers and the elderly, can be vaccinated by June, vaccinated by September, and more time consuming. .. India is the lowest-income country in the first economic group, including Hong Kong, China, Singapore and Malaysia. Wealer South Korea and Thailand will take longer.
The Serum Institute’s work requires a reliable, high-volume domestic supply of vials in which vaccines are sealed and transported, assured by companies such as Schott Kaisha and Pilamar Glass. The presence of the world’s largest vaccine manufacturer helps to lay the foundation for a domestic network of suppliers.
The world’s supply chain and international trade have actually held up very well in extreme circumstances over the past year. There is no need to rebuild huge volumes of manufacturing capacity, and attempts at a half-hearted closed economy will reduce the prosperity of all involved (importers and exporters).
But when it comes to manufacturing important items that may face a massive surge in demand, and when national priorities come to the fore, countries can take a break from Indian books. Doing so is impractical for all small and medium-sized countries, but production can be organized at the level of regional blocks such as the Association of Southeast Asian Nations. The pandemic has hit Latin America more than many other parts of the world, but due to limited vaccine production, most countries have been waiting in front of them for a long time.
Such a company does not have to be a state-owned enterprise. As mentioned earlier, the Serum Institute works closely with the government, but was founded as a private sector and is still a private sector. Establishing similar capabilities can be achieved through cooperation on healthcare regulation and appropriate financial incentives to create large regional markets. This principle applies explicitly to personal protective equipment as well as vaccines.
Many much wealthier countries are plagued by a shortage of these important components, as they are usually imported, and the demand is so high that supply is currently uncertain. Given the very slow pace of European vaccine deployment, the Indian program has the potential to become a model for the world.
Write to Mike Bird at Mike.Bird@wsj.com
Copyright © 2020 DowJones & Company, Inc. all rights reserved. 87990cbe856818d5eddac44c7b1cdeb8
Indian Vaccine Colossus is a model the world should follow
